Gene · 6046
Papers3,414
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,414
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells. | Int J Mol Sci | 2024 | 38255982 | PubTator, text mining | PubMed |
| Kaposi's sarcoma herpesvirus latency-associated nuclear antigen broadly regulates viral gene expression and is essential for lytic infection. | PLoS Pathog | 2024 | 38232124 | PubTator, text mining | PubMed |
| Abstracts of the 27th Annual Congress of the SBRA. Aracaju/SE - Brazil, 2023. | JBRA Assist Reprod | 2024 | 38230867 | PubTator, text mining | PubMed |
| Chemical Catalysis Guides Structural Identification for the Major In Vivo Metabolite of the BET Inhibitor JQ1. | ACS Med Chem Lett | 2024 | 38229743 | PubTator, text mining | PubMed |
| BRD2 and BRD3 genes independently evolved RNA structures to control unproductive splicing. | NAR Genom Bioinform | 2024 | 38226395 | PubTator, text mining | PubMed |
| Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. | Cell Death Discov | 2024 | 38225241 | PubTator, text mining | PubMed |
| Therapeutic Approaches to Targeting Androgen Receptor Splice Variants. | Cells | 2024 | 38201308 | PubTator, text mining | PubMed |
| Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein-Ligand Interactions and High Selectivity. | J Med Chem | 2024 | 38197367 | PubTator, text mining | PubMed |
| The multifaceted interactions between Newcastle disease virus proteins and host proteins: a systematic review. | Virulence | 2024 | 38193514 | PubTator, text mining | PubMed |
| Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks. | J Exp Clin Cancer Res | 2024 | 38183103 | PubTator, text mining | PubMed |
| Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1. | Theranostics | 2024 | 38169595 | PubTator, text mining | PubMed |
| CD146/MCAM links doxorubicin-induced epigenetic dysregulation to the impaired fatty acid transportation in H9c2 cardiomyoblasts. | Biochem Biophys Res Commun | 2024 | 38100998 | PubTator, text mining | PubMed |
| Bromodomain Proteins Epigenetically Regulate the Mitotically Associated lncRNA MANCR in Triple Negative Breast Cancer Cells. | Crit Rev Eukaryot Gene Expr | 2024 | 38073442 | PubTator, text mining | PubMed |
| A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer. | Clin Cancer Res | 2024 | 37992310 | PubTator, text mining | PubMed |
| Blood DNA methylation signature of diet quality and association with cardiometabolic traits. | Eur J Prev Cardiol | 2024 | 37793095 | PubTator, text mining | PubMed |
| Multigenerational diabetes mellitus. | Front Endocrinol (Lausanne) | 2023 | 38288471 | PubTator, text mining | PubMed |
| The Role of the AT-Rich Interaction Domain 1A Gene (ARID1A) in Human Carcinogenesis. | Genes (Basel) | 2023 | 38275587 | PubTator, text mining | PubMed |
| Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications. | Front Immunol | 2023 | 38268926 | PubTator, text mining | PubMed |
| Primary pulmonary nuclear protein of the testis midline carcinoma: case report and systematic review with pooled analysis. | Front Oncol | 2023 | 38264746 | PubTator, text mining | PubMed |
| Melatonin: a modulator in metabolic rewiring in T-cell malignancies. | Front Oncol | 2023 | 38260850 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6046/papers?page=8